Aderamastat
Modify Date: 2024-03-07 12:06:57
Aderamastat structure
|
Common Name | Aderamastat | ||
|---|---|---|---|---|
| CAS Number | 877176-23-3 | Molecular Weight | 394.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H18N2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AderamastatAderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor. Aderamastat can be used for the research of asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis[1]. |
| Name | Aderamastat |
|---|
| Description | Aderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor. Aderamastat can be used for the research of asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Li, Yuhua, et al. Safe administration of MMP-12 inhibitor. Patent. WO2022261624 A1. |
| Molecular Formula | C21H18N2O4S |
|---|---|
| Molecular Weight | 394.44 |